PharmaRoth Labs, Inc.
ROTH · OTC
6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $1,140 | $1,460 | $1,612 | $3,228 |
| - Cash | $1 | $1 | $1 | $6 |
| + Debt | $250 | $250 | $0 | $0 |
| Enterprise Value | $1,389 | $1,709 | $1,611 | $3,222 |
| Revenue | $182 | $263 | $87 | $529 |
| % Growth | -31.1% | 202.9% | -83.6% | – |
| Gross Profit | $73 | $108 | $27 | $316 |
| % Margin | 40% | 41% | 31% | 59.8% |
| EBITDA | -$92 | -$233 | -$370 | -$292 |
| % Margin | -50.4% | -88.4% | -425.4% | -55.2% |
| Net Income | -$92 | -$233 | -$370 | -$291 |
| % Margin | -50.4% | -88.4% | -425.1% | -55% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 66.7% | 50% | -20% | – |
| Operating Cash Flow | -$18 | -$86 | -$31 | -$215 |
| Capital Expenditures | $0 | $86 | $31 | $215 |
| Free Cash Flow | -$18 | $0 | $0 | $0 |